國立虎尾科技大學 |

Respiratory delivery of biologics, nucleic acids, and vaccines

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Respiratory delivery of biologics, nucleic acids, and vaccines/ edited by Jenny Lam, Philip Chi Lip Kwok.
其他作者:	Lam, Jenny.
出版者:	Cham :Springer International Publishing : : 2023.,
面頁冊數:	x, 216 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer Nature eBook
標題:	Drug delivery systems. -
電子資源:	https://doi.org/10.1007/978-3-031-47567-2
ISBN:	9783031475672

Respiratory delivery of biologics, nucleic acids, and vaccines
Respiratory delivery of biologics, nucleic acids, and vaccines[electronic resource] /edited by Jenny Lam, Philip Chi Lip Kwok. - Cham :Springer International Publishing :2023. - x, 216 p. :ill. (some col.), digital ;24 cm. - AAPS introductions in the pharmaceutical sciences,v. 82522-8358 ;. - AAPS introductions in the pharmaceutical sciences ;v. 13..

Chapter 1: Design strategies of dry powders for pulmonary delivery of pharmaceutical peptides -- Chapter 2. Pulmonary delivery of antibody for the treatment of respiratory diseases -- Chapter 3: Dry powder formulation of monoclonal antibodies for pulmonary delivery -- Chapter 4: Antimicrobial peptides and proteins for inhalation -- Chapter 5: Pulmonary delivery of nucleic acids -- Chapter 6: Intranasal and inhaled vaccines -- Chapter 7: Respiratory delivery of probiotics to improve lung health -- Chapter 8: Respiratory delivery of bacteriophages for the treatment of lung infections -- Chapter 9: Pharmacokinetics of inhaled medications - what do we know about biological macromolecules?.

Therapeutic macromolecules and biologics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these therapeutic modalities, which have poor oral bioavailability, could constitute an attractive, non-invasive alternative to parenteral delivery. They can be considered for either topical use for treating diseases affecting the airways or for systemic use for treating a variety of other diseases. Therefore, this book is a readable, thoughtful, and useful guide on the latest research developments and the best options that people involved with pulmonary and intranasal route of administration and biologically active agents can bring to their practices. Furthermore, it explores the underlying scientific rationale for the strategies applied to overcome drug delivery challenges and provides insights to inspire further research in this growing area.

ISBN: 9783031475672

Standard No.: 10.1007/978-3-031-47567-2doiSubjects--Topical Terms:

581921
Drug delivery systems.

LC Class. No.: RS199.5

Dewey Class. No.: 615.6

Respiratory delivery of biologics, nucleic acids, and vaccines
LDR:02661nam a2200337 a 4500 001 1120793
003 DE-He213
005 20240119143630.0
006 m d
007 cr nn 008maaau
008 240612s2023 sz s 0 eng d
020 $a 9783031475672 $q (electronic bk.)
020 $a 9783031475665 $q (paper)
024 7 $a 10.1007/978-3-031-47567-2 $2 doi
035 $a 978-3-031-47567-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RS199.5
072 7 $a PSB $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a PNB $2 thema
082 0 4 $a 615.6 $2 23
090 $a RS199.5 $b .R434 2023
245 0 0 $a Respiratory delivery of biologics, nucleic acids, and vaccines $h [electronic resource] / $c edited by Jenny Lam, Philip Chi Lip Kwok.
260 $a Cham : $c 2023. $b Springer International Publishing : $b Imprint: Springer,
300 $a x, 216 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a AAPS introductions in the pharmaceutical sciences, $x 2522-8358 ; $v v. 8
505 0 $a Chapter 1: Design strategies of dry powders for pulmonary delivery of pharmaceutical peptides -- Chapter 2. Pulmonary delivery of antibody for the treatment of respiratory diseases -- Chapter 3: Dry powder formulation of monoclonal antibodies for pulmonary delivery -- Chapter 4: Antimicrobial peptides and proteins for inhalation -- Chapter 5: Pulmonary delivery of nucleic acids -- Chapter 6: Intranasal and inhaled vaccines -- Chapter 7: Respiratory delivery of probiotics to improve lung health -- Chapter 8: Respiratory delivery of bacteriophages for the treatment of lung infections -- Chapter 9: Pharmacokinetics of inhaled medications - what do we know about biological macromolecules?.
520 $a Therapeutic macromolecules and biologics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these therapeutic modalities, which have poor oral bioavailability, could constitute an attractive, non-invasive alternative to parenteral delivery. They can be considered for either topical use for treating diseases affecting the airways or for systemic use for treating a variety of other diseases. Therefore, this book is a readable, thoughtful, and useful guide on the latest research developments and the best options that people involved with pulmonary and intranasal route of administration and biologically active agents can bring to their practices. Furthermore, it explores the underlying scientific rationale for the strategies applied to overcome drug delivery challenges and provides insights to inspire further research in this growing area.
650 0 $a Drug delivery systems. $3 581921
650 0 $a Lungs $x Diseases $x Chemotherapy. $3 1436285
650 0 $a Biologicals. $3 1023555
650 0 $a Inhalers. $3 1000483
650 1 4 $a Pharmaceutics. $3 1366841
650 2 4 $a Drug Delivery. $3 1366630
650 2 4 $a Biologics. $3 1393782
650 2 4 $a Biomaterials-Vaccines. $3 1394946
650 2 4 $a Structure-Based Drug Design. $3 1366842
650 2 4 $a Pharmacology. $3 583819
700 1 $a Lam, Jenny. $3 1436284
700 1 $a Kwok, Philip Chi Lip. $3 1236032
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
830 0 $a AAPS introductions in the pharmaceutical sciences ; $v v. 13. $3 1416732
856 4 0 $u https://doi.org/10.1007/978-3-031-47567-2
950 $a Medicine (SpringerNature-11650)